Literature DB >> 11035776

Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha.

A Venkateswaran1, B A Laffitte, S B Joseph, P A Mak, D C Wilpitz, P A Edwards, P Tontonoz.   

Abstract

LXR alpha is a nuclear receptor that has previously been shown to regulate the metabolic conversion of cholesterol to bile acids. Here we define a role for this transcription factor in the control of cellular cholesterol efflux. We demonstrate that retroviral expression of LXR alpha in NIH 3T3 fibroblasts or RAW264.7 macrophages and/or treatment of these cells with oxysterol ligands of LXR results in 7- to 30-fold induction of the mRNA encoding the putative cholesterol/phospholipid transporter ATP-binding cassette (ABC)A1. In contrast, induction of ABCA1 mRNA in response to oxysterols is attenuated in cells that constitutively express dominant-negative forms of LXR alpha or LXR beta that lack the AF2 transcriptional activation domain. We further demonstrate that expression of LXR alpha in NIH 3T3 fibroblasts and/or treatment of these cells with oxysterols is sufficient to stimulate cholesterol efflux to extracellular apolipoprotein AI. The ability of oxysterol ligands of LXR to stimulate efflux is dramatically reduced in Tangier fibroblasts, which carry a loss of function mutation in the ABCA1 gene. Taken together, these results indicate that cellular cholesterol efflux is controlled, at least in part, at the level of transcription by a nuclear receptor-signaling pathway. They suggest a model in which activation of LXRs by oxysterols in response to cellular sterol loading leads to induction of the ABCA1 transporter and the stimulation of lipid efflux to extracellular acceptors. These findings have important implications for our understanding of mammalian cholesterol homeostasis and suggest new opportunities for pharmacological regulation of cellular lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035776      PMCID: PMC17300          DOI: 10.1073/pnas.200367697

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.

Authors:  M Bodzioch; E Orsó; J Klucken; T Langmann; A Böttcher; W Diederich; W Drobnik; S Barlage; C Büchler; M Porsch-Ozcürümez; W E Kaminski; H W Hahmann; K Oette; G Rothe; C Aslanidis; K J Lackner; G Schmitz
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

2.  Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency.

Authors:  A Brooks-Wilson; M Marcil; S M Clee; L H Zhang; K Roomp; M van Dam; L Yu; C Brewer; J A Collins; H O Molhuizen; O Loubser; B F Ouelette; K Fichter; K J Ashbourne-Excoffon; C W Sensen; S Scherer; S Mott; M Denis; D Martindale; J Frohlich; K Morgan; B Koop; S Pimstone; J J Kastelein; J Genest; M R Hayden
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

3.  Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages.

Authors:  T Langmann; J Klucken; M Reil; G Liebisch; M F Luciani; G Chimini; W E Kaminski; G Schmitz
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

Review 4.  Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system.

Authors:  Y Yamada; T Doi; T Hamakubo; T Kodama
Journal:  Cell Mol Life Sci       Date:  1998-07       Impact factor: 9.261

Review 5.  The LXRs: a new class of oxysterol receptors.

Authors:  D J Peet; B A Janowski; D J Mangelsdorf
Journal:  Curr Opin Genet Dev       Date:  1998-10       Impact factor: 5.578

6.  Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta.

Authors:  B A Janowski; M J Grogan; S A Jones; G B Wisely; S A Kliewer; E J Corey; D J Mangelsdorf
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

7.  Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR.

Authors:  P J Willy; D J Mangelsdorf
Journal:  Genes Dev       Date:  1997-02-01       Impact factor: 11.361

8.  Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1.

Authors:  S Rust; M Rosier; H Funke; J Real; Z Amoura; J C Piette; J F Deleuze; H B Brewer; N Duverger; P Denèfle; G Assmann
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

9.  The orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolism.

Authors:  B M Forman; B Ruan; J Chen; G J Schroepfer; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

10.  The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway.

Authors:  R M Lawn; D P Wade; M R Garvin; X Wang; K Schwartz; J G Porter; J J Seilhamer; A M Vaughan; J F Oram
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

View more
  297 in total

1.  Identification of macrophage liver X receptors as inhibitors of atherosclerosis.

Authors:  Rajendra K Tangirala; Eric D Bischoff; Sean B Joseph; Brandee L Wagner; Robert Walczak; Bryan A Laffitte; Chris L Daige; Diane Thomas; Richard A Heyman; David J Mangelsdorf; Xuping Wang; Aldons J Lusis; Peter Tontonoz; Ira G Schulman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-22       Impact factor: 11.205

Review 2.  Reverse cholesterol transport: high-density lipoprotein's magnificent mile.

Authors:  Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 3.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

4.  The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease.

Authors:  Gurdeep Marwarha; Turk Rhen; Trevor Schommer; Othman Ghribi
Journal:  J Neurochem       Date:  2011-10-24       Impact factor: 5.372

5.  Liver X receptor β and peroxisome proliferator-activated receptor δ regulate cholesterol transport in murine cholangiocytes.

Authors:  Xuefeng Xia; Dongju Jung; Paul Webb; Aijun Zhang; Bin Zhang; Lifei Li; Stephen D Ayers; Chiara Gabbi; Yoshiyuki Ueno; Jan-Åke Gustafsson; Gianfranco Alpini; David D Moore; Gene D Lesage
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

6.  Common and Differential Transcriptional Actions of Nuclear Receptors Liver X Receptors α and β in Macrophages.

Authors:  Ana Ramón-Vázquez; Juan Vladimir de la Rosa; Carlos Tabraue; Felix Lopez; Bonifacio Nicolas Díaz-Chico; Lisardo Bosca; Peter Tontonoz; Susana Alemany; Antonio Castrillo
Journal:  Mol Cell Biol       Date:  2019-02-15       Impact factor: 4.272

Review 7.  ATP binding cassette transporter A1--key roles in cellular lipid transport and atherosclerosis.

Authors:  Neelam Srivastava
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

8.  Alterations of Cholesterol Metabolism in Inflammation-Induced Atherogenesis.

Authors:  David P Hajjar; Katherine A Hajjar
Journal:  J Enzymol Metab       Date:  2016-05-31

9.  28-Homobrassinolide: a novel oxysterol transactivating LXR gene expression.

Authors:  R Premalatha; K Srikumar; D Vijayalaksmi; G N Kumar; P P Mathur
Journal:  Mol Biol Rep       Date:  2014-08-05       Impact factor: 2.316

10.  Autoregulation of the human liver X receptor alpha promoter.

Authors:  B A Laffitte; S B Joseph; R Walczak; L Pei; D C Wilpitz; J L Collins; P Tontonoz
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.